Not Just for Kids: Spotlight on RSV in Older Adults

Download All
Join the experts to learn about the severe clinical manifestations caused by respiratory syncytial virus in older patients. Diagnostic challenges, recent adult vaccine safety and efficacy data, and barriers to adult vaccine implementation in primary care settings will be presented. Watch the on-demand webinar, download the slides, and read the companion expert-authored ClinicalThought commentaries.
John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH
Pamela Rockwell, DO, FAAFP

ClinicalThought

RSV is underdiagnosed in older adults, and future vaccines may reduce its burden in this population. Here are my thoughts on RSV vaccine development and where the vaccines may fit in the current immunization schedule.

Laura Hurley, MD, MPH Released: September 19, 2022

An RSV vaccine, if approved, may reduce disease burden in older adults. Here are our ideas on overcoming barriers to the implementation of vaccines for older adults in primary care settings.

John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP
Released: October 17, 2022

Want to learn more about RSV vaccines? Read my commentary about the latest data presented at the IDWeek 2022 meeting.

Pamela Rockwell, DO, FAAFP Released: December 23, 2022

Downloadable Slidesets

Download these slides from a live symposium for an expert review of RSV in adults and the progress on developing RSV vaccines, with strategies to overcome vaccination barriers in primary care.

John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP
Released: October 12, 2022

Download this short summary of key slides from a live symposium for RSV in adults and the progress on developing RSV vaccines, with strategies to overcome vaccination barriers in primary care.

John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP
Released: October 24, 2022

On-Demand Webcast

Listen as expert faculty discuss the impact of RSV in adults and the progress on developing RSV vaccines, with strategies to overcome vaccination barriers in primary care.

John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Released: October 28, 2022 Expired: No longer available for credit

Podcast

Listen as Laura Hurley, MD, MPH; John J. Russell, MD, FAAFP; and Pamela Rockwell, DO, FAAFP, discuss the progress on developing RSV vaccines, with strategies to overcome vaccination barriers in primary care.

John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP
Released: November 3, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings